抗苗勒管激素作为辅助生殖后活产的预测因素:对2012-2013年辅助生殖技术临床结局报告系统数据库中85,062个新鲜与解冻周期的分析
该回顾性分析基于2012-2013年辅助生殖技术临床结局报告系统数据库,纳入70,565个有胚胎移植的新鲜与冻融周期,评估血清抗苗勒管激素(AMH)与活产的关系。AMH与新鲜及冻融周期的活产显著相关,在校正年龄、体质指数、种族、移植日及移植胚胎数后为独立预测因素,但受试者工作特征曲线下面积分别为0.631和0.540,提示AMH单独预测活产能力弱。
要点
- 在85,062个有AMH记录的新鲜与冻融周期中,70,565个有胚胎移植的周期纳入分析。
- AMH与新鲜及冻融周期的活产显著相关,校正混杂因素后为独立预测因素。
- AMH预测活产的受试者工作特征曲线下面积新鲜周期为0.631、冻融周期为0.540,单独预测能力弱。
核心结论
- AMH对新鲜或冻融胚胎移植、无论选择性单胚胎移植还是非单胚胎移植的活产结局均为弱独立预测因素。
研究设计与样本
- 回顾性分析2012至2013年辅助生殖技术临床结局报告系统数据库。
- 共85,062个新鲜与冻融自体非植入前遗传学诊断周期有AMH记录,其中70,565个有胚胎移植的周期纳入分析。
主要发现
- 血清AMH与新鲜及冻融周期每移植活产结局显著相关。
- 多因素logistic回归在校正年龄、体质指数、种族、移植日及移植胚胎数后,AMH为新鲜及冻融周期活产的独立预测因素。
- 受试者工作特征曲线下面积新鲜周期为0.631、解冻周期为0.540,提示AMH单独预测活产能力弱。
- 选择性单胚胎移植周期单独分析时,新鲜周期曲线下面积为0.655、冻融周期为0.533,但AMH在选择性单胚胎移植周期中不是独立预测因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine if serum antimüllerian hormone (AMH) is associated with and/or predictive of live birth assisted reproductive technology (ART) outcomes. DESIGN: Retrospective analysis of Society for Assisted Reproductive Technology Clinic Outcome Reporting System database from 2012 to 2013. SETTING: Not applicable. PATIENT(S): A total of 69,336 (81.8%) fresh and 15,458 (18.2%) frozen embryo transfer (FET) cycles with AMH values. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Live birth. RESULT(S): A total of 85,062 out of 259,499 (32.7%) fresh and frozen-thawed autologous non-preimplantation genetic diagnosis cycles had AMH reported for cycles over this 2-year period. Of those, 70,565 cycles which had embryo transfers were included in the analysis. Serum AMH was significantly associated with live birth outcome per transfer in both fresh and FET cycles. Multiple logistic regression demonstrated that AMH is an independent predictor of live birth in fresh transfer cycles and FET cycles when controlling for age, body mass index, race, day of transfer, and number of embryos transferred. Receiver operating characteristic (ROC) curves demonstrated that the areas under the curve (AUC) for AMH as predictors of live birth in fresh cycles and thawed cycles were 0.631 and 0.540, respectively, suggesting that AMH alone is a weak independent predictor of live birth after ART. Similar ROC curves were obtained also when elective single-embryo transfer (eSET) cycles were analyzed separately in either fresh (AUC 0.655) or FET (AUC 0.533) cycles, although AMH was not found to be an independent predictor in eSET cycles. CONCLUSION(S): AMH is a poor independent predictor of live birth outcome in either fresh or frozen embryo transfer for both eSET and non-SET transfers.
引用
- Tal R, Seifer DB, Wantman E, et al. Antimüllerian hormone as a predictor of live birth following assisted reproduction: an analysis of 85,062 fresh and thawed cycles from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database for 2012-2013. Fertil Steril. 2018. PMID: 29331235. doi:10.1016/j.fertnstert.2017.10.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。